234 related articles for article (PubMed ID: 15728708)
1. LPA2 receptor mediates mitogenic signals in human colon cancer cells.
Yun CC; Sun H; Wang D; Rusovici R; Castleberry A; Hall RA; Shim H
Am J Physiol Cell Physiol; 2005 Jul; 289(1):C2-11. PubMed ID: 15728708
[TBL] [Abstract][Full Text] [Related]
2. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.
Chen M; Towers LN; O'Connor KL
Am J Physiol Cell Physiol; 2007 May; 292(5):C1927-33. PubMed ID: 17496233
[TBL] [Abstract][Full Text] [Related]
3. MAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cells.
Lee SJ; Ritter SL; Zhang H; Shim H; Hall RA; Yun CC
Gastroenterology; 2011 Mar; 140(3):924-34. PubMed ID: 21134377
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells.
Yu S; Murph MM; Lu Y; Liu S; Hall HS; Liu J; Stephens C; Fang X; Mills GB
J Natl Cancer Inst; 2008 Nov; 100(22):1630-42. PubMed ID: 19001604
[TBL] [Abstract][Full Text] [Related]
5. LPA-induced migration of ovarian cancer cells requires activation of ERM proteins via LPA
Park J; Jang JH; Oh S; Kim M; Shin C; Jeong M; Heo K; Park JB; Kim SR; Oh YS
Cell Signal; 2018 Apr; 44():138-147. PubMed ID: 29329782
[TBL] [Abstract][Full Text] [Related]
6. Differential targeting of lysophosphatidic acid LPA
Olianas MC; Dedoni S; Onali P
Eur J Pharmacol; 2023 Nov; 959():176064. PubMed ID: 37758013
[TBL] [Abstract][Full Text] [Related]
7. NHERF2 specifically interacts with LPA2 receptor and defines the specificity and efficiency of receptor-mediated phospholipase C-beta3 activation.
Oh YS; Jo NW; Choi JW; Kim HS; Seo SW; Kang KO; Hwang JI; Heo K; Kim SH; Kim YH; Kim IH; Kim JH; Banno Y; Ryu SH; Suh PG
Mol Cell Biol; 2004 Jun; 24(11):5069-79. PubMed ID: 15143197
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1.
Shida D; Kitayama J; Yamaguchi H; Okaji Y; Tsuno NH; Watanabe T; Takuwa Y; Nagawa H
Cancer Res; 2003 Apr; 63(7):1706-11. PubMed ID: 12670925
[TBL] [Abstract][Full Text] [Related]
9. Antidepressants activate the lysophosphatidic acid receptor LPA(1) to induce insulin-like growth factor-I receptor transactivation, stimulation of ERK1/2 signaling and cell proliferation in CHO-K1 fibroblasts.
Olianas MC; Dedoni S; Onali P
Biochem Pharmacol; 2015 Jun; 95(4):311-23. PubMed ID: 25888927
[TBL] [Abstract][Full Text] [Related]
10. Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq.
Kim J; Keys JR; Eckhart AD
Cell Signal; 2006 Oct; 18(10):1695-701. PubMed ID: 16504475
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid stimulates the intestinal brush border Na(+)/H(+) exchanger 3 and fluid absorption via LPA(5) and NHERF2.
Lin S; Yeruva S; He P; Singh AK; Zhang H; Chen M; Lamprecht G; de Jonge HR; Tse M; Donowitz M; Hogema BM; Chun J; Seidler U; Yun CC
Gastroenterology; 2010 Feb; 138(2):649-58. PubMed ID: 19800338
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer.
Shida D; Watanabe T; Aoki J; Hama K; Kitayama J; Sonoda H; Kishi Y; Yamaguchi H; Sasaki S; Sako A; Konishi T; Arai H; Nagawa H
Lab Invest; 2004 Oct; 84(10):1352-62. PubMed ID: 15220934
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation and Internalization of Lysophosphatidic Acid Receptors LPA1, LPA2, and LPA3.
Alcántara-Hernández R; Hernández-Méndez A; Campos-Martínez GA; Meizoso-Huesca A; García-Sáinz JA
PLoS One; 2015; 10(10):e0140583. PubMed ID: 26473723
[TBL] [Abstract][Full Text] [Related]
14. LPA receptor 2 mediates LPA-induced endometrial cancer invasion.
Hope JM; Wang FQ; Whyte JS; Ariztia EV; Abdalla W; Long K; Fishman DA
Gynecol Oncol; 2009 Jan; 112(1):215-23. PubMed ID: 19019417
[TBL] [Abstract][Full Text] [Related]
15. Specific LPA receptor subtype mediation of LPA-induced hypertrophy of cardiac myocytes and involvement of Akt and NFkappaB signal pathways.
Chen J; Chen Y; Zhu W; Han Y; Han B; Xu R; Deng L; Cai Y; Cong X; Yang Y; Hu S; Chen X
J Cell Biochem; 2008 Apr; 103(6):1718-31. PubMed ID: 17891781
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid receptor 2 and Gi/Src pathway mediate cell motility through cyclooxygenase 2 expression in CAOV-3 ovarian cancer cells.
Jeong KJ; Park SY; Seo JH; Lee KB; Choi WS; Han JW; Kang JK; Park CG; Kim YK; Lee HY
Exp Mol Med; 2008 Dec; 40(6):607-16. PubMed ID: 19116446
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid facilitates proliferation of colon cancer cells via induction of Krüppel-like factor 5.
Zhang H; Bialkowska A; Rusovici R; Chanchevalap S; Shim H; Katz JP; Yang VW; Yun CC
J Biol Chem; 2007 May; 282(21):15541-9. PubMed ID: 17430902
[TBL] [Abstract][Full Text] [Related]
18. Deletion of Na+/H+ exchanger regulatory factor 2 represses colon cancer progress by suppression of Stat3 and CD24.
Yoshida M; Zhao L; Grigoryan G; Shim H; He P; Yun CC
Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(8):G586-98. PubMed ID: 26867566
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid signaling through LPA receptor subtype 1 induces colony scattering of gastrointestinal cancer cells.
Shin KJ; Kim YL; Lee S; Kim DK; Ahn C; Chung J; Seong JY; Hwang JI
J Cancer Res Clin Oncol; 2009 Jan; 135(1):45-52. PubMed ID: 18592268
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS
Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]